Cite
HARVARD Citation
Heaney, L. et al. (2021). Composite type-2 biomarker strategy versus a symptom–risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trial. Lancet. 9 (1), pp. 57-68. [Online].